Skip to content

Content transparency

  • Published:
  • Updated:
  • Editorial record: · no verified named reviewer is attached
  • Sources: 3 references listed
Authorship, review and conflicts
Named author
No verified public author identity is recorded for this page. Dog Tumor is the publisher; no veterinary authorship is implied.
Clinical review
No verified named veterinary or subject-matter reviewer is recorded for this page.
Conflicts
No page-specific conflict statement is recorded. Read the editorial standards.
Directory Entry

Maropitant for Nausea and Vomiting Support in Cancer Care

Antiemetic / Nausea Support · Prescription Drug · Dogs & Cats · During Chemotherapy · Long-term Management · Palliative / Comfort Care · Published Study
Common name: Maropitant citrateEditorial source check: Dog Tumor Editorial Team (editorial review; not licensed veterinary review)Last reviewed: Aug 12, 2026Official link: Visit
Directory entry:This page explains what the product, drug, herb, chemotherapy approach, or supportive-care option is. For step-by-step use or monitoring, read related Guides and consult a veterinarian.

Quick summary

Maropitant is a prescription antiemetic used for selected dogs and cats, but controlling vomiting does not identify or resolve every cause of nausea or gastrointestinal disease.

What it is

Maropitant blocks neurokinin signaling involved in vomiting and is available in veterinary formulations and routes. The prescriber selects timing and formulation based on species, age, cause, organ function, other medicines, and ability to keep medication down.

How it is discussed in tumor care

It may be used preventively or as rescue support around chemotherapy, anesthesia, radiation, medication effects, or another diagnosed cause. Good symptom control can support hydration, food intake, comfort, and treatment continuity.

Potential role

A symptom-control plan may protect comfort, hydration, nutrition, sleep, mobility, and treatment continuity while the team also investigates the cause. Success means a defined improvement in the patient’s function or comfort, not simply suppressing a warning sign.

Typical use context

The prescriber considers the suspected cause, severity, organ function, cancer treatment, comorbidities, all medicines and supplements, previous reactions, and what can safely be managed at home. Families need written start, stop, missed-dose, and escalation instructions.

Evidence snapshot

Current oncology guidance lists maropitant among antiemetic options, and veterinary references describe its clinical use. Absence of vomiting does not prove that nausea, obstruction, pancreatitis, pain, or other disease has resolved.

Safety notes

Injection discomfort, gastrointestinal or behavioral changes, hypersensitivity, liver-related considerations, and drug interactions may matter. Repeated vomiting, abdominal pain or distension, blood, severe weakness, or inability to keep water down needs reassessment.

Interactions / cautions

Do not use another pet’s or a person’s medicine, combine products, repeat a vomited dose, or alter a prescription without instructions. Severe weakness, collapse, breathing difficulty, uncontrolled pain, repeated vomiting, inability to urinate, major bleeding, or rapid deterioration warrants urgent assessment.

Questions to ask your veterinarian

  • Is maropitant being used for prevention, rescue, or a diagnosed cause, and what signs mean the plan failed?
  • What observable comfort or function goal should improve?
  • Which interactions, organ risks, or sedation effects matter for this patient?
  • When should we hold the medicine, call the clinic, or seek emergency care?

Sources and further reading